Boytz R, Slabicki M, Ramaswamy S, Patten JJ, et al. Anti-SARS-CoV-2 Activity of Targeted Kinase Inhibitors: Repurposing Clinically Available Drugs for COVID-19 Therapy. J Med Virol 2022 Sep 18. doi: 10.1002/jmv.28157.
PMID: 36117402